Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06763835

Novel Serum Biomarkers for Identifying Plaque Erosion in ACS and Predicting Prognosis

Sponsor: Xuebo Liu

View on ClinicalTrials.gov

Summary

The goal of this observational study is to find novel serum biomarkers for the accurate diagnosis of plaque erosion (PE) from acute coronary syndrome (ACS) and help predicting the prognosis of PE. The main question it aims to answer is • Whether novel serum biomarkers could facilitate the non-invasive diagnosis and prognosis prediction of PE ? Participants will be contacted at 1,2,5 year after the diagnosis of PE-ACS or other reasons of ACS.

Official title: Development and Validation of Diagnostic and Prognostic Model of Acute Coronary Syndrome Caused by Plaque Erosion Using Novel Serum Biomarkers

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

OBSERVATIONAL

Enrollment

301

Start Date

2023-02-01

Completion Date

2026-07-30

Last Updated

2025-01-14

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Blood is drawn to test for specific biomarkers

After identifying characteristic biomarkers that can distinguish between PE-ACS and PR-ACS, we draw blood from ACS patients for testing to assist in determining whether the ACS subtype is PE-ACS or PR-ACS.

Locations (1)

Tongji Hospital, Tongj University School of Medicine, 200333, Shanghai ,China

Shanghai, China